Am J Transplant, Volume 5, Suppl 3 Archives - Page 85 of 170 - ATC Abstracts

2015 American Transplant Congress
The Impact of Ischemia/Reperfusion Injury On Liver Allografts from Deceased After Cardiac Death Versus Deceased After Brain Death Donors
B. Sayed, J. Xu, A. Casas-Ferreira, P. Srinivasan, N. Heaton, Y. Ma, C. Legido-Quigley, S. Fuggle, W. Jassem.
1Liver Transplant Unit, Institute of Liver Studies, King's College Hospital, London, United Kingdom; Department of Transplant Surgery, Emory University, Atlanta, United Kingdom; Institute of Pharmaceutical Science, King's College Hospital, London, United Kingdom; Department of Analytical Chemistry, University of Salamanca, Salamanca, Spain; Nuffield Department of Surgery, University of Oxford, Oxford, United Kingdom.
Background and Aims:The shortage of appropriate organs for transplantation has led to the use of organs from donors after cardiac death. The pathophysiologic processes associated…
2015 American Transplant Congress
Outcomes Following Endovascular Treatment of Hepatic Artery Stenosis Following Liver Transplantation
J. Seal,¹ H. Bohorquez,¹ L. Le,² W. Terral,² A. Cohen,¹ I. Carmody,¹ D. Bruce,¹ T. Reichman,¹ E. Ahmed,¹ W. Sternbergh,² G. Loss.¹
¹Multi-Organ Transplant Institute, Ochsner Health System, New Orleans, LA; ²Department of Surgery, Ochsner Health Systems, New Orleans, LA.
Endovascular treatment of hepatic artery stenosis (HAS) after liver transplantation offers a less invasive alternative to surgical revision or retransplantation. However, outcomes following endovascular treatment…
2015 American Transplant Congress
Birth Weight as a Marker of Nephron Mass: Impact on Renal Allograft Function
T. Schachtner,^1,2 P. Reinke.^1,2
¹Nephrology and Internal Intensive Care, Charité Campus Virchow Clinic, Berlin, Germany; ²Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany.
Nephron number has been considered a major determinant of renal allograft function and outcome. It has been demonstrated that low birth weights give rise to…
2015 American Transplant Congress
Learning from Failures: A 7-Year Analysis of a Multi-Institutional Kidney Paired Donation Registry
D. Fumo,^1,2 V. Kapoor,¹ L. Reece,² S. Rees,² J. Kopke,² S. Stepkowski,¹ C. Smith,^1,2 M. Rees.^1,2
¹University of Toledo Medical Center, Toledo, OH; ²Alliance for Paired Donation, Maumee, OH.
Failure to convert computer-identified possible Kidney Paired Donation (KPD) exchanges into transplants has prevented KPD from reaching its full potential. The purpose of this study…
2015 American Transplant Congress
The Impact of Preoperative Antimicrobial Prophylaxis on Device-Related Infections in Recipients of Long-Term Mechanical Circulatory Support (MCS)
I. El Lakkis,¹ K. Lietz,² C. Derber,¹ U. Kelly,¹ C. Wilson,¹ A. Hoedt,² P. Bourasssa,² B. Smith,² M. McGrath,² J. Herre,² M. Mooney.¹
¹Eastern Virginia Medical School, Norfolk, VA; ²Sentara Norfolk General Hospital, Norfolk, VA.
Purpose: Although preoperative antimicrobial prophylaxis is recommended for patients undergoing long-term MCS device implantation, there is a lack of consensus as to the optimal preoperative…
2015 American Transplant Congress
Inadequate Overall Immunosuppression Is a Risk for Late Acute Rejection Despite Alemtuzumab Induction in Simultaneous Pancreas Kidney Transplant Recipients
J. Bank,¹ M. Mallat,¹ P. van der Boog,¹ D. Braat,² J. Ringers,² M. Vergunst,³ S. Heidt,³ F. Claas,³ M. Reinders,¹ J. de Fijter.¹
¹Nephrology, LUMC, Leiden, Netherlands; ²Surgery, LUMC, Leiden, Netherlands; ³IHB, LUMC, Leiden, Netherlands.
Introduction: Simultaneous pancreas-kidney transplantation (SPK) has become the treatment of choice for patients with end-stage renal disease due to Type 1 Diabetes Mellitus. SPK is…
2015 American Transplant Congress
Dual Induction Therapy With Anti-Thymocyte Globulin and Basiliximab in Simultaneous Pancreas-Kidney Transplantation Reduced Incidence of Acute Rejection
K. Miki, K. Iwadoh, I. Nakajima, S. Fuchinoue.
Tokyo Women Medical University, Kidney Center, Tokyo, Kawadacho, Japan.
【Background】Induction therapy in simultaneous pancreas-kidney transplant (SPK) recipients has been a common practice because a consequence of acute rejection (AR) in SPK could result in…
2015 American Transplant Congress
Kidney Retransplantation in the Ipsilateral Iliac Fossa; a Surgical Challenge
L. Ooms,¹ J. Roodnat,² F. Dor,¹ K. Tran,¹ D. Kimenai,¹ J. IJzermans,¹ T. Terkivatan.¹
¹Transplant Surgery, Erasmus Medical Center, Rotterdam, Netherlands; ²Nephrology, Erasmus Medical Center, Rotterdam, Netherlands.
Introduction: The aim of this study is to review the surgical outcome of kidney retransplantation in the ipsilateral iliac fossa in comparison to first kidney…
2015 American Transplant Congress
DNA Methylation of the IFNγ Promoter in CD8+ T Cell Subsets Is Modulated by CMV Infection but not by Alloreactivity in Kidney Transplantation Patients
K. Boer,¹ E. de Wit,¹ L. Hofland,² M. Betjes,¹ C. Baan.¹
¹Internal Medicine - Nephrology and Transplantation, Erasmus University Medical Center, Rotterdam, Netherlands; ²Internal Medicine - Endocrinology, Erasmus University Medical Center, Rotterdam, Netherlands.
Introduction DNA methylation plays a critical role in the function of cells, including cells of the immune system. Little is known about the methylation status…
2015 American Transplant Congress
Frequencies of CD4⁺25^hiFoxp3⁺T Cells in Long-Term Follow-Up of Sirolimus-Converted Kidney Transplant Recipients
O. Traitanon,^1,2 A. Alvarado,¹ E. Tantisattamo,^1,2 A. Shetty,^1,2 M. Ansari,^1,2 J. Mathew,¹ J. Leventhal,¹ V. Mas,³ L. Gallon.^1,2
¹Comprehensive Transplant Center, Northwestern University, Chicago, IL; ²Medicine-Nephrology, Northwestern University, Chicago, IL; ³Surgery, University of Virginia, Charlottesville, VA.
Background: Tacrolimus(TAC) and Sirolimus(SRL) are commonly used immunosuppressive drugs in kidney transplantation. SRL has been shown to induce the expansion of regulatory T cells in…